International trade · 01/05/2013Updated: 10/17/2026 · 1 min read
US International Trade Commission Investigates ResMed Corporation for Patent Infringement on Sleep-Disordered Breathing Treatment Systems
Summary
The US International Trade Commission has launched an investigation into ResMed Corporation, ResMed Incorporated, and ResMed Limited for allegedly infringing on several patents related to sleep-disordered breathing treatment systems, following a complaint filed on March 28, 2013, under section 337 of the Tariff Act of 1930.
Original source language: Federal Register — International Trade CommissionOpen original release →